OOIR: Observatory of International Research

Papers

(The TQCC of JAMA Dermatology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Error in Author Surname in Byline	144
Can Serum Biomarkers for Prurigo Nodularis Expose Pathophysiology or Just Treatment Response?	139
Melanoma Screening	139
Group Omitted From Article Byline	115
Frequency of Skin Biopsies for Psoriasis by Race and Ethnicity	112
Exanthematous Eruption in a Patient With Known Chronic Graft-vs-Host Disease and Recent Measles Vaccination	91
Assessment of Cutaneous Vasculitis and Quality of Life	90
Recurrence Rate of Melanoma In Situ Excised With a 5-mm Excisional Margin	89
Asymptomatic Irregular Pigmented Lesions of the Vulva	84
Treatment With Ataluren for Wound Healing and Health Complications in a Patient With Junctional Epidermolysis Bullosa	83
Safety and Efficacy of ICP-332 for Moderate to Severe Atopic Dermatitis	79
Outcomes Associated With Combination Shaving and Cryosurgery Treatment in Patients With Keloid Scars	78
SIGLEC-1 Expression in a Cohort of Patients With Lupus Erythematosus Treated With Anifrolumab	73
Prevalence and Patient Characteristics of Ectodermal Dysplasias in Denmark	71
Treatment With Topical Sirolimus for Recurrent Lymphatic Malformation of the External Urethral Meatus	70
Cutaneous Angiosarcoma	69
JAMA Dermatology	68
Pregabalin for Neuropathic Pain and Itch in Recessive Dystrophic Epidermolysis Bullosa	67
Perceptions of US-Based Muslim Patients of Their Dermatology Care	67
Subclinical Synovitis Among Patients With Psoriasis Without Musculoskeletal Involvement	66
Preventing Hand-Foot Syndrome in Patients With Cancer	65
Incidence, In-Hospital and Long-Term Mortality, and Sequelae of Epidermal Necrolysis in Adults	64
Adalimumab Monotherapy vs Adalimumab With Methotrexate for Psoriasis	61
Skin Cancer Care in US Veterans—Serving Those Who Served	60
GLP-1 Receptor Agonists in Hidradenitis Suppurativa—Emerging Opportunities for Comorbidity Management?	60

Low-Dose Metformin and Profibrotic Signature in Central Centrifugal Cicatricial Alopecia	59
Tofacitinib for Treatment of Acquired Reactive Perforating Collagenosis	58
Parvovirus B19 Infection	58
Clinical and Pathological Spectrum of Prurigo Pigmentosa in Central European Individuals	58
Disordered Eating in Hidradenitis Suppurativa	57
Ultraprocessed Food Intake and Psoriasis	57
Prevalence of Contact Allergens in Natural Skin Care Products From US Commercial Retailers	56
Biomarkers of Tretinoin Precursors and Tretinoin Efficacy in Patients With Moderate to Severe Facial Photodamage	55
Smoking Cessation and Risk of Hidradenitis Suppurativa Development	55
Measuring Atopic Eczema Control and Itch Intensity in Clinical Practice	54
Parental E-Cigarette Use and Pediatric Atopic Dermatitis	53
Treatment of Severe Palmoplantar Pustular Psoriasis With Bimekizumab	53
Alopecia Areata	52
Nicotinamide for Skin Cancer Chemoprevention	50
Current State of Dermatology Mobile Applications With Artificial Intelligence Features	50
Human Papillomavirus Diversity in Asian Individuals With Cutaneous Squamous Cell Carcinoma	49
Understanding Flares in Patients With Generalized Pustular Psoriasis Documented in US Electronic Health Records	48
Immune Checkpoint Inhibitors in Field Cancerization and Keratinocyte Cancer Prevention	48
ALK-Positive Histiocytosis—A Distinct Histiocytic Entity Deserving Recognition—Reply	48
COVID-19 as a Risk Factor For Autoimmune Skin Disease	47
JAMA Dermatology	47
Reexamining Medication Impact in Hidradenitis Suppurativa and Pregnancy—Reply	46
Errors in Abstract, Results, and Table 1	46
Treatment of Severe Dermatitis, Multiple Allergies, and Metabolic Wasting With Dupilumab	45
Serum Immunoglobulin G Levels and Nicastrin Variation in Hidradenitis Suppurativa	44
Considerations Regarding Mohs Surgery for Early-Stage Merkel Cell Carcinoma	43
The Quest for a More Accurate Diagnosis of Cellulitis	43
Cooling Research Fever in Dermatology—The Role of Community Service—Reply	43
Methotrexate and Interstitial Lung Disease—Reply	43
Spesolimab Response in a Patient With Steroid-Resistant Sweet Syndrome	41
Supporting Dermatologic Health Services Research for Structurally Marginalized Patients	41
Multiple Papules and Nodules on the Face and Extremities	40
Errors in Figure 2	40
Foscarnet-Induced Penile Ulceration	39
Error in Figure 4	38
Validation of Case Identification for Melasma Using International Statistical Classification of Diseases and Related Health Problems, Tenth Revision Codes	38
Alectinib In the Treatment of Systemic Juvenile Xanthogranuloma of Infancy With ALK Translocation	37
Nocturnal Pruritus Associated With Poultry Red Mite Bites	36
A Subcutaneous Nodule With a Central Punctum on the Thigh	36
Sun Protection 101—Your Guide to Sunscreen	36
Rapid Improvement in Refractory Acute Generalized Exanthematous Pustulosis With Spesolimab	36
Antihypertensive Medications and Eczematous Dermatitis in Older Adults	35
Consensus Guidelines for Staging and Surveillance Imaging in Cutaneous Squamous Cell Carcinoma	35
Mohs Surgery vs Wide Local Excision in Primary High-Stage Cutaneous Squamous Cell Carcinoma	35
Guselkumab for Moderate to Severe Scalp Psoriasis Across All Skin Tones	35
Cardiovascular and Venous Thromboembolic Risk With JAK Inhibitors in Immune-Mediated Inflammatory Skin Diseases	34
Validation of the 2022 National Comprehensive Cancer Network Risk Stratification for Cutaneous Squamous Cell Carcinoma	34
Trends in the Prevalence of Eczema Among US Children by Age, Sex, Race, and Ethnicity From 1997 to 2018	34
Clinical Characteristics Associated With Response to Biologics in the Treatment of Psoriasis	33
Federated Learning for Decentralized Artificial Intelligence in Melanoma Diagnostics	33

Errors in Figure 2 and Table 2 Footnotes	32
Numerous Angiomatous Lesions in an Infant	32
A Firm Pigmented Plaque on the Forearm of a Child	32
Error in Figure 1	32
Efficacy, Safety, and Tolerability of Oral DFD-29, a Low-Dose Formulation of Minocycline, in Rosacea	31
JAMA Dermatology Peer Reviewers in 2022	31
Chloracne	31
Chemotherapy-Induced Pseudocellulitis Without Prior Radiation Exposure	30
Treatment of Actinic Keratosis via Destruction in Medicare Beneficiaries	29
A Tribute to Samuel Moschella	29
Safety and Efficacy of Topical Lovastatin Plus Cholesterol Cream vs Topical Lovastatin Cream Alone for the Treatment of Disseminated Superficial Actinic Porokeratosis	29
Presentation, Diagnosis, and Treatment of Cutaneous Crohn Disease	29
Error in Author Byline	28
Legislative Efforts Restricting Care for Transgender People	28
Error in Table	28
Value-Driven Skin Cancer Surveillance for Transplant Recipients	27
Development and Validation of a Scale to Assess Epidermolysis Bullosa Simplex Severity	27
Red Papulonodules in a Kidney Transplant Recipient	27
JAMA Dermatology	26
Research Fever in Dermatology—A Symptom of a Larger Problem	26
Incidence and Prevalence of Morphea	26
Association of Different Prescribing Patterns for Oral Corticosteroids With Fracture Preventive Care Among Older Adults in the UK and Ontario	26
Incorporating Social Determinants of Health Into Medical Decision-making—Implications for Dermatology	25
Standardization of Lesion Classification and Assessment by Investigators in Clinical Trials for Hidradenitis Suppurativa	25
Hidradenitis Suppurativa and Smoking, Obesity, Psoriasis, Inflammatory Bowel Disease, and Systemic Sclerosis	25
High-Dose Upadacitinib Therapy for Refractory Metastatic Crohn Disease	24
International Eczema Council Definitions of Low Disease Activity and Remission in Atopic Dermatitis	24
Clinical and Pathologic Factors in Stage I and II Melanoma Recurrence	24
Roflumilast Foam, 0.3%, for Psoriasis of the Scalp and Body	24
Risk of New-Onset and Recurrent Depression and Anxiety Among Patients With Hidradenitis Suppurativa	24
Use of Reflectance Confocal Microscopy in Equivocal Lesions for the Diagnosis of Melanoma	24
Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus	24
Use of Patient-Reported Outcomes in Acne Vulgaris and Rosacea Clinical Trials From 2011 to 2021	24
Error in Table Footnote	24
Recurrence Rate of Small Melanoma In Situ on Low-Risk Sites Excised With 5-mm Excisional Margin	23
Errors in the Affiliations and Corresponding Author Sections	23
CLOVES Syndrome	23
Epidermolysis Bullosa Pruriginosa Treated With Upadacitinib	23
Recurring Papules and Nodules on the Vulva	23
Association of Biologic Treatment in Hidradenitis Suppurativa With Reduced Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio	23
Doxycycline Postexposure Prophylaxis (DoxyPEP) for Bacterial STI Prevention	23
Xeroradiography as a Noninvasive Tool in Diagnosing Calciphylaxis	23
Skin-Related Quality of Life During Autoimmune Bullous Disease Course	22
Emergomycosis Without Immunodeficiency	22
Outcomes Associated With Neutropenia and Lymphopenia in Epidermal Necrolysis	22
Prevalence of Comorbidities Among Pediatric Patients With Hidradenitis Suppurativa	22
Consent and Identifiability for Patient Images in Research, Education, and Image-Based Artificial Intelligence	22
Mendelian Randomization for Dermatology Research	22
Symptoms of Cognitive Impairment Among Children With Atopic Dermatitis	22
Global Psoriasis Burden and Forecasts to 2050	21
Isotretinoin Treatment in Adolescence and Adult Height	21
Ecthymalike Ulcerations in Patients With Lung Cancer Treated With Combined Amivantamab and Osimertinib	21
Differences in Face-to-Face Time Spent With a Dermatologist Among Patients With Psoriasis Based on Race and Ethnicity	21
Botulinum Toxin for Refractory Digital Ischemia and Ulcers in Systemic Sclerosis	20
JAK2 Fusions in Adult Patients With Mycosis Fungoides and CD30 Lymphoproliferative Disorders	20
Smooth, Firm, Skin-Colored Papules on the Nasal Dorsum	20
Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy	20
Successful Treatment of Stimulator of Interferon Genes–Associated Vasculopathy of Infantile Onset SAVI Syndrome With Anifrolumab	20
Cutaneous Herpetiform Ulcerations as the Presenting Sign of an Acute Aortic Occlusion	20
Potential Sexual Transmission of Tinea Pubogenitalis From TMVII	20
Palmar Fasciitis and Polyarthritis Syndrome	20
Evaluation of Gabapentin and Transforaminal Corticosteroid Injections for Brachioradial Pruritus	19
JAMA Dermatology	19
Annular Erythematous Eruption in a Pediatric Patient	19
Projective Personification Approach to the Experience of People With Acne and Acne Scarring—Expressing the Unspoken	19
Fibromyalgia in Patients With Hidradenitis Suppurativa	19
Acrodermatitis Enteropathica	19
JAMA Dermatology Peer Reviewers in 2024	19
Safety and Efficacy of Anti–IL-23 Monoclonal Antibody QX004N for Patients With Psoriasis	19
Solitary Verrucous Plaque on the Right Pretibial Region	18
Artificial Intelligence and Dermatology	18
Cost-Utility Analysis of Rituximab vs Mycophenolate Mofetil for the Treatment of Pemphigus Vulgaris	18
Systemic Proteomic Alterations and Predictive Biomarkers of Paroxetine Response in Refractory Rosacea	18
Error in Text	18
Errors in Byline and Figures 3 and 4	18
Keratinocyte Cancer Risk and Porokeratosis Mevalonate Pathway Variants	18
Assessment of Need for Improved Identification of a Culprit Drug in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis	18
Benign Familial Pemphigus in Skin of Color	18
Diversity and Career Goals of Graduating Allopathic Medical Students Pursuing Careers in Dermatology	18
Reframing and Corrections to Review of ICD Codes for Dermatologic Conditions	18

Targeting Cardiometabolic Disease to Improve Psoriasis—A New Treatment Paradigm Emerges	17
Characterizing Chronic Cutaneous Immune-Related Adverse Events Following Immune Checkpoint Inhibitors	17
CLAPO Syndrome	17
Baricitinib Withdrawal and Retreatment in Patients With Severe Alopecia Areata	17
HLA-B*58:01 and Risk of Allopurinol-Induced Severe Cutaneous Adverse Reactions in the US	17
Diagnosis, Workup, and Treatment of Idiopathic Granulomatous Mastitis	17
Sudden Conjunctivitis, Lymphopenia, and Rash Combined With Hemodynamic Changes (SCoRCH) After Trimethoprim-Sulfamethoxazole Use	17
Cobblestoning Monomorphic Papules of the Lower Extremities	17
It Is Time to End Routine Laboratory Monitoring for Isotretinoin	17
Epitope Spreading in Immune Checkpoint Inhibitor–Associated Bullous Pemphigoid	17
Comorbidities of Keloid and Hypertrophic Scars Among Participants in UK Biobank	16
Geographic Distribution and Workforce Diversity of Dermatology Physician Assistants—Reply	16
A Reddish Semitransparent Tumor in an Adolescent Girl	16
JAMA Dermatology	16
Eruptive Xanthomas	16
Granulomatous Cheilitis in a Young Woman	16
Prevalence of Pretreatment Testing Recommended for Patients With Chronic Inflammatory Skin Diseases	16
Pott Puffy Tumor	16
Incidence Trends of Cutaneous Squamous Cell Carcinoma, Carcinoma In Situ, and Keratoacanthoma By Sex, Age, and Anatomical Site	16
Eruptive Acral Nevi Secondary to Treatment With Chemotherapy	16
Patient Perspectives on Living With Severe Prurigo Nodularis	16
Improvement of Hailey-Hailey Disease With Topical Cinacalcet, 3%, Ointment	16
Response of Severe Lupus Miliaris Disseminatus Faciei to Treatment With Ruxolitinib Cream	15
Adjuvant Immunotherapy in Stage II Melanoma—Further Risk Stratification is Needed	15
Delphi Panel for the Development of Diagnostic Criteria for Metastatic Cutaneous Crohn Disease	15
Treatment of Netherton Syndrome With Abrocitinib	15
Outcomes of COVID-19 and Vaccination in Patients With Moderate to Severe Atopic Dermatitis Treated With Tralokinumab	15
Radiation Recall Dermatitis With Bruton Tyrosine Kinase Inhibitor Therapy	15
Genetic Susceptibility to Hidradenitis Suppurativa and Predisposition to Cardiometabolic Disease	15
Global Applicability of a Risk Prediction Tool for Sentinel Node Positivity in Patients With Primary Cutaneous Melanoma	15
Granulomatosis With Polyangiitis Presenting With Strawberry Gums	15
Outpatient Dermatology Productivity Measures by Patient Race, Sex, and Age	15
Generalized Atrophic Papules and Acute Abdominal Pain	15
Upadacitinib in Adolescents With Moderate to Severe Atopic Dermatitis	15
Safety and Effectiveness of Oral Nutraceuticals for Treating Acne	15
Tuberculous Mastitis	14
Error in Box	14
JAMA Dermatology	14
Unusual Congenital Scalp Lesion in a Child	14
Perspectives and Strategies to Minimize Harm From Melanoma Diagnosis	14
Home- vs Office-Based Narrowband UV-B Phototherapy for Patients With Psoriasis	14
Olmsted Syndrome	14
Facilitators and Barriers to the Timely Diagnosis and Treatment of Melanoma in Latino Persons	14
Annular Cutaneous Lesion of the Neck	14
Clinical Features and Outcomes of Black Patients With Melanoma	14
Pigmentary Changes in a Woman With Oral Lichen Planus	14
Topical β-Blocker Wet Wrap Therapy for Amivantamab-Induced Scalp and Facial Necrosis	14
Hypertrophic Tongue Papillae in Cowden Syndrome/PTEN Hamartoma Tumor Syndrome	14
Chronic Mucocutaneous Candidiasis Due to STAT1 Gene Variant	14
Hereditary Leukonychia Associated With GJA1 Mutation	14
Reanalysis Following Removal of Participants From 1 Site in Multicenter Trial of Upadacitinib vs Dupilumab for Atopic Dermatitis	13
Treatment of Porokeratosis Ptychotropica With a Topical Combination of Cholesterol and Simvastatin	13
Evidence-Based Clinical Practice Guidelines for Laser-Assisted Drug Delivery	13
Melasma	13
Reanalysis of Study After Removal of Participants in 1 Trial of Upadacitinib for Atopic Dermatitis	13
Sunburn and Cutaneous Squamous Cell Carcinoma	13
Gene-Environment Interaction Between CYP1B1 and Oral Contraception on Frontal Fibrosing Alopecia	13
JAMA Dermatology	13
Incidence and Factors Associated With Second Primary Invasive Melanoma in Norway	13
Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children	13
Cutaneous Adverse Events and Cancer Survival Prognosis With Immune Checkpoint Inhibitor Treatment	13
Onychomycosis	13
Response of Widespread Generalized Essential Telangiectasia Following Treatment With Oral Dabigatran	13
Cost-Effectiveness Analysis of 3D Total-Body Photography for People at High Risk of Melanoma	13
Intralesional Interleukin-2 Therapy for Treatment of Cutaneous Squamous Cell Carcinoma	13
Mogamulizumab-Associated Kaposi Sarcoma in 2 Patients With Primary Cutaneous T-Cell Lymphomas	13
Rapidly Enlarging Erythematous Plaque of the Forearm in an Older Man	13
Genetic Variants Associated With Hidradenitis Suppurativa	13
Relevance of Human Herpesvirus 6 Reactivation in Drug Rash With Eosinophilia and Systemic Symptoms—Reply	13
Treatment of Suspected Rubella Virus–Associated Granulomatous Dermatitis With Adalimumab	13
Online vs In-Person Care for Atopic Dermatitis	12
JAMA Dermatology’s Commitment to Diversity, Equity, and Inclusion	12
Sarcoidosis of the Skin	12
Improving Outcomes in Chronic Graft-vs-Host Disease	12
Successful Treatment of Recalcitrant Mpox Lesions With Intralesional Cidofovir in a Patient With HIV/AIDS	12
Association Between Low-Dose Methotrexate Exposure and Melanoma	12
Intralesional Certolizumab for Refractory Lupus Pernio	12
Genital and Perigenital “W”-Shaped Telangiectasias in Women With Limited Cutaneous Systemic Sclerosis	12
Evaluation of Clinical Relevance and Biological Effects of Antirituximab Antibodies in Patients With Pemphigus	12
Clinical Associations of Degos-Like Lesions in Patients With Systemic Sclerosis	12
Evaluation of the Validity of International Classification of Diseases Codes for Dermatologic Conditions	12
JAMA Dermatology	12
Cutaneous Anthrax	12
Prevention of Skin Cancers With Topical Calcipotriol and Fluorouracil in Patients With Xeroderma Pigmentosum	12
Risk of Alopecia Areata After COVID-19	12
The Consideration of Cyclosporine in the Treatment of Stevens-Johnson Syndrome	12
Measuring the Carbon Footprint of Dermatology	11
Hunter Syndrome	11
Salt and Atopic Dermatitis—Reply	11
Sarcoidosis-Specific Cutaneous Lesion Distribution in Clinical Assessment for Cardiac Sarcoidosis	11
Use of Dupilumab to Manage Antibody-Drug Conjugate–Induced Cutaneous Toxicities	11
Botulinum Toxin A for the Treatment of Yellow Nail Syndrome and Palmar Primary Hyperhidrosis	11
Evaluation of Stigma Toward Individuals With Acne	11
Tzanck Smear of Ulcerated Plaques	11
Association of Tumor Characteristics With Insurance Type Among Patients Undergoing Mohs Micrographic Surgery for Nonmelanoma Skin Cancer	11